The Medicines Manufacturing Industry Partnership (MMIP) represents the voice of medicines manufacturers in the UK. It was established jointly by the Government and the biopharmaceutical industry in 2014 to ensure that the UK is recognised by the global medicines industry as a world-class advanced centre for medicines manufacturing.
The UK's medicines industry is one of the country's leading manufacturing sectors, and one of the UK’s highest value exports.
The Partnership aims to ensure that the UK continues to be an attractive place for this high-value industry to secure exports, provide high skilled job opportunities and contribute to solving the country's productivity puzzle.
The UK Life Sciences Vision recognised the sector’s high productivity and the MMIP is now an expert group under the direction of the Life Sciences Council.
Working closely with key government organisations including Innovate UK and the Office for Life Sciences (OLS), MMIP is continuously working to sustain the UK's leading position in medicines manufacturing technologies, including those related to advanced therapy medicinal products (ATMPs), leadership in sustainable medicines production, and continuous production and digitalisation.
In June 2023 the MMIP published ‘Follow the green, high-tech road: A path to UK growth, net zero and health resilience from innovation in medicines manufacturing’.
The report sets out a comprehensive 10-year plan to return the UK to its status as a world leader in advanced medicines manufacturing.
To make progress on this shared agenda, the MMIP is structured into workstreams.
- the technology and innovation landscape
- the fiscal environment
- the regulatory environment
- the skills environment
- Advanced Therapies manufacturing
The MMIP is supported by the ABPI, the BioIndustry Association (BIA), the Knowledge Transfer Network, and a range of leading biopharmaceutical manufacturers.
For more information please contact:
- Joe Edwards – Director of UK Competitiveness and Devolved Nations
Related news and blogs
Medicines manufacturing has the potential to drive UK growth over the next 10 years
Recent successes in supplying high-value medicines and in advanced therapies manufacture must be built on, according to a cross-industry coalition.
Pfizer’s Brian Henry appointed head of UK medicines manufacturing partnership
The Medicines Manufacturing Industry Partnership (MMIP) represents the voice of medicines manufacturing in the UK.
Speech: The future of medicines manufacturing
Richard Torbett spoke to the MMIP Annual Conference about the future of UK medicines manufacturing.